Zinc-Children-Hospitalized-Pneumonia

Not Applicable

• Conditions: community-acquired pneumonia; Pneumonia; Lung Diseases; Respiratory Tract Diseases; Respiratory Tract Infections

• Registration Number: RPCEC00000325
• Lead Sponsor: Autonomous Service Antonio Patricio de Alcalá University Hospital (SAHUAPA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-09
• Study Completion: 2020-07-31
• Results First Posted: 2020-08-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1.The diagnosis of pneumonia was considered in that child with fever (T ° = 38.5 ° C) in the presence of signs and symptoms such as respiratory distress, retractions or draws and cough accompanied by radiological changes.

Exclusion Criteria

The following were excluded from the study:
1. Patients with congenital malformations
2. Patients immunosuppressed by drugs or primary diseases of the immune system
3. Patients with suspected foreign body aspiration
4. Previous hospitalizations in the last 4 weeks
5. Presence of wheezing as dominant findings.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Resolution of pneumonia (Time measured in hours required to normalize the clinical elements that defined the pneumonia). Measurement time: from the moment of admission until normal<br> <br>

Secondary Outcome Measures

Name	Time	Method
Remission rate of clinical indicators of pneumonia in percentage. Measurement time: at 72 hours’ intervention started<br>2. Therapeutic failure (Need to change the initial antibiotic, the appearance of complications or the persistence of hypoxemia). Measurement time: at 72 hours’ intervention started<br>3. Adverse effects (Any reaction related to the intervention). Measurement time: up to 14 days.<br>